| 000 | 00815 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514022600.0 | ||
| 264 | 0 | _c20020226 | |
| 008 | 200202s 0 0 jpn d | ||
| 022 | _a0022-9776 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aToyota, E | |
| 245 | 0 | 0 |
_a[DOTS in Japan--Tokyo area]. _h[electronic resource] |
| 260 |
_bKekkaku : [Tuberculosis] _cDec 2001 |
||
| 300 |
_a749-53 p. _bdigital |
||
| 500 | _aPublication Type: Lecture | ||
| 650 | 0 | 4 | _aCommunicable Disease Control |
| 650 | 0 | 4 | _aCommunity Health Services |
| 650 | 0 | 4 | _aDirectly Observed Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 |
_aTokyo _xepidemiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 773 | 0 |
_tKekkaku : [Tuberculosis] _gvol. 76 _gno. 12 _gp. 749-53 |
|
| 999 |
_c11716824 _d11716824 |
||